Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Ann Surg. 2023 Jul 1;278(1):e87-e93. doi: 10.1097/SLA.0000000000005494. Epub 2022 Jul 4.
The objective of this study was to identify the indications for and report the outcomes of completion pancreatectomy (CPLP) in the postoperative course after pancreatoduodenectomy (PD).
CPLP may be considered or even inevitable for damage control after PD.
A prospectively maintained database of all patients undergoing PD between 2001 and 2019 was searched for patients who underwent CPLP in the postoperative course after PD. Baseline characteristics, perioperative details, and outcomes of CPLP patients were analyzed and specific indications for CPLP were identified.
A total of 3953 consecutive patients underwent PD during the observation period. CPLP was performed in 120 patients (3%) after a median of 10 days following PD. The main indications for CPLP included postpancreatectomy acute necrotizing pancreatitis [n=47 (39%)] and postoperative pancreatic fistula complicated by hemorrhage [n=41 (34%)] or associated with uncontrollable leakage of the pancreatoenteric anastomosis [n=23 (19%)]. The overall 90-day mortality rate of all 3953 patients was 3.5% and 37% for patients undergoing CPLP.
Our finding that only very few patients (3%) need CPLP suggests that conservative, interventional, and organ-preserving surgical measures are the mainstay of complication management after PD. Postpancreatectomy acute necrotizing pancreatitis, uncontrollable postoperative pancreatic fistula, and fistula-associated hemorrhage are highly dangerous and represent the main indications for CPLP after PD.
本研究旨在明确胰十二指肠切除术后(PD)完成胰腺切除术(CPLP)的适应证,并报告其结果。
CPLP 可能是 PD 后损伤控制的考虑因素,甚至是必要手段。
对 2001 年至 2019 年间所有接受 PD 的患者进行前瞻性维护的数据库进行搜索,以寻找 PD 术后行 CPLP 的患者。分析 CPLP 患者的基线特征、围手术期细节和结局,并确定 CPLP 的具体适应证。
在观察期间,共有 3953 例连续患者接受 PD。CPLP 在 PD 后中位 10 天进行,共 120 例(3%)患者接受 CPLP。CPLP 的主要适应证包括胰十二指肠切除术后急性坏死性胰腺炎(n=47,39%)、术后胰腺瘘伴出血(n=41,34%)或与不可控的胰肠吻合口漏相关(n=23,19%)。所有 3953 例患者的 90 天总死亡率为 3.5%,行 CPLP 患者的死亡率为 37%。
我们发现只有极少数患者(3%)需要 CPLP,这表明在 PD 后,保守、介入和器官保留手术措施是并发症管理的主要方法。胰十二指肠切除术后急性坏死性胰腺炎、不可控的术后胰腺瘘和瘘相关出血是非常危险的,是 PD 后行 CPLP 的主要适应证。